Company profile
Palisade Bio, Inc. Insider Trading
PALIEvery SEC Form 4 insider trading filing for Palisade Bio, Inc. (PALI) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001357459
- Filings
- 89
- Insiders
- 14
- Last filing
- 2026-08-19
Activity summary
No insider transactions in the last 30 days. The most recent was on August 19, 2026, when John David Finley sold 88,400 shares. 89 filings from 14 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Palisade Bio, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $410K.
90 day insight
Over the last 90 days, Palisade Bio, Inc. insiders bought $250K (12 transactions) and sold $410K (2 transactions).
- Most active insider: John David Finley with 7 transactions totaling $303K.
- Largest single sale: $303K by John David Finley on Jul 7, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | John David Finley | PALI | Gift | 88,400 | — | — |
| Aug 19, 2026 | John David Finley | PALI | Gift | 88,400 | — | — |
| Jul 9, 2026 | Robert Baltera Jr. | PALI | Purchase | 25,000 | $1.96 | $49K |
| Jul 8, 2026 | Robert Baltera Jr. | PALI | Purchase | 20,000 | $1.99 | $40K |
| Jul 7, 2026 | John David Finley | PALI | Sale | 146,798 | $2.07 | $303K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=PALI" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Palisade Bio, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →